These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 25034438)
1. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea. Lee JS; Oh M; ; Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438 [TBL] [Abstract][Full Text] [Related]
2. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227 [TBL] [Abstract][Full Text] [Related]
3. Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Cui Y; Deming-Halverson SL; Shrubsole MJ; Beeghly-Fadiel A; Fair AM; Sanderson M; Shu XO; Kelley MC; Zheng W Clin Breast Cancer; 2014 Dec; 14(6):417-25. PubMed ID: 24970715 [TBL] [Abstract][Full Text] [Related]
4. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357 [TBL] [Abstract][Full Text] [Related]
5. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: a case-case study. Song N; Choi JY; Sung H; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D Int J Cancer; 2014 Aug; 135(3):669-81. PubMed ID: 24916400 [TBL] [Abstract][Full Text] [Related]
8. Association between common risk factors and molecular subtypes in breast cancer patients. Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738 [TBL] [Abstract][Full Text] [Related]
9. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe. Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121 [TBL] [Abstract][Full Text] [Related]
10. Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Sun X; Nichols HB; Tse CK; Bell MB; Robinson WR; Sherman ME; Olshan AF; Troester MA Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):60-7. PubMed ID: 26545404 [TBL] [Abstract][Full Text] [Related]
11. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study. Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840 [TBL] [Abstract][Full Text] [Related]
12. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591 [TBL] [Abstract][Full Text] [Related]
13. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study. Chitkara A; Mesa-Eguiagaray I; Wild SH; Hall PS; Cameron DA; Sims AH; Figueroa JD Breast Cancer Res Treat; 2022 Nov; 196(2):379-387. PubMed ID: 36116093 [TBL] [Abstract][Full Text] [Related]
14. Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China. Wang JM; Wang J; Zhao HG; Liu TT; Wang FY Biomed Res Int; 2020; 2020():5931529. PubMed ID: 32337260 [TBL] [Abstract][Full Text] [Related]
15. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466 [TBL] [Abstract][Full Text] [Related]
16. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
17. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M; Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648 [TBL] [Abstract][Full Text] [Related]
18. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis. Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982 [TBL] [Abstract][Full Text] [Related]
19. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Lambertini M; Santoro L; Del Mastro L; Nguyen B; Livraghi L; Ugolini D; Peccatori FA; Azim HA Cancer Treat Rev; 2016 Sep; 49():65-76. PubMed ID: 27529149 [TBL] [Abstract][Full Text] [Related]
20. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]